Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review
- PMID: 37222772
- PMCID: PMC10317894
- DOI: 10.1007/s00125-023-05926-3
Patient-reported outcomes for people with diabetes: what and how to measure? A narrative review
Abstract
Patient-reported outcomes (PROs) are valuable for shared decision making and research. Patient-reported outcome measures (PROMs) are questionnaires used to measure PROs, such as health-related quality of life (HRQL). Although core outcome sets for trials and clinical practice have been developed separately, they, as well as other initiatives, recommend different PROs and PROMs. In research and clinical practice, different PROMs are used (some generic, some disease-specific), which measure many different things. This is a threat to the validity of research and clinical findings in the field of diabetes. In this narrative review, we aim to provide recommendations for the selection of relevant PROs and psychometrically sound PROMs for people with diabetes for use in clinical practice and research. Based on a general conceptual framework of PROs, we suggest that relevant PROs to measure in people with diabetes are: disease-specific symptoms (e.g. worries about hypoglycaemia and diabetes distress), general symptoms (e.g. fatigue and depression), functional status, general health perceptions and overall quality of life. Generic PROMs such as the 36-Item Short Form Health Survey (SF-36), WHO Disability Assessment Schedule (WHODAS 2.0), or Patient-Reported Outcomes Measurement Information System (PROMIS) measures could be considered to measure commonly relevant PROs, supplemented with disease-specific PROMs where needed. However, none of the existing diabetes-specific PROM scales has been sufficiently validated, although the Diabetes Symptom Self-Care Inventory (DSSCI) for measuring diabetes-specific symptoms and the Diabetes Distress Scale (DDS) and Problem Areas in Diabetes (PAID) for measuring distress showed sufficient content validity. Standardisation and use of relevant PROs and psychometrically sound PROMs can help inform people with diabetes about the expected course of disease and treatment, for shared decision making, to monitor outcomes and to improve healthcare. We recommend further validation studies of diabetes-specific PROMs that have sufficient content validity for measuring disease-specific symptoms and consider generic item banks developed based on item response theory for measuring commonly relevant PROs.
Keywords: Diabetes; Patient-reported outcome; Patient-reported outcome measure; Review; Standardisation.
© 2023. The Author(s).
Figures
Similar articles
-
The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.Diabetologia. 2021 Jun;64(6):1213-1225. doi: 10.1007/s00125-021-05382-x. Epub 2021 Feb 2. Diabetologia. 2021. PMID: 33528625 Free PMC article.
-
Development of a standard set of PROs and generic PROMs for Dutch medical specialist care : Recommendations from the Outcome-Based Healthcare Program Working Group Generic PROMs.Qual Life Res. 2023 Jun;32(6):1595-1605. doi: 10.1007/s11136-022-03328-3. Epub 2023 Feb 9. Qual Life Res. 2023. PMID: 36757571 Free PMC article.
-
Common patient-reported outcomes across ICHOM Standard Sets: the potential contribution of PROMIS®.BMC Med Inform Decis Mak. 2021 Sep 6;21(1):259. doi: 10.1186/s12911-021-01624-5. BMC Med Inform Decis Mak. 2021. PMID: 34488730 Free PMC article.
-
Health-related Quality of Life Assessment in Renal Cell Cancer: A Scoping Review.Eur Urol Oncol. 2025 Feb;8(1):201-212. doi: 10.1016/j.euo.2024.09.007. Epub 2024 Oct 4. Eur Urol Oncol. 2025. PMID: 39366818
-
Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Acne Vulgaris: A Systematic Review of Measure Development and Measurement Properties.JAMA Dermatol. 2022 Aug 1;158(8):900-911. doi: 10.1001/jamadermatol.2022.2260. JAMA Dermatol. 2022. PMID: 35731537 Free PMC article.
Cited by
-
Socioeconomic inequalities in health-related functioning among people with type 2 Diabetes: longitudinal analyses in the Maastricht Study.BMC Public Health. 2024 Jan 3;24(1):73. doi: 10.1186/s12889-023-17553-z. BMC Public Health. 2024. PMID: 38172697 Free PMC article.
-
Effectiveness of Educational and Psychoeducational Self-Management Interventions in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-Analysis.Pediatr Diabetes. 2024 Oct 8;2024:2921845. doi: 10.1155/2024/2921845. eCollection 2024. Pediatr Diabetes. 2024. PMID: 40302946 Free PMC article.
-
Perceptions of use and value for different types of digital health solutions among people with type 1 and 2 diabetes in France.Acta Diabetol. 2025 Aug 8. doi: 10.1007/s00592-025-02564-6. Online ahead of print. Acta Diabetol. 2025. PMID: 40779203
-
Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges.World J Diabetes. 2024 May 15;15(5):828-852. doi: 10.4239/wjd.v15.i5.828. World J Diabetes. 2024. PMID: 38766443 Free PMC article. Review.
-
Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals.BMJ Ment Health. 2024 Aug 25;27(1):e301061. doi: 10.1136/bmjment-2024-301061. BMJ Ment Health. 2024. PMID: 39182922 Free PMC article.
References
-
- U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH) (2009) Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
-
- Harman NL, Wilding JPH, Curry D, et al. Selecting core outcomes for randomised effectiveness trials in type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes. BMJ Open Diabetes Res Care. 2019;7(1):e000700. doi: 10.1136/bmjdrc-2019-000700. - DOI - PMC - PubMed
-
- ICHOM (2019) Type 1 and Type 2 Diabetes in Adults. DATA COLLECTION REFERENCE GUIDE. Available from https://connect.ichom.org/patient-centered-outcome-measures/diabetes/ Accessed 30 Mar 2023
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous